Research Article

Combined Analysis of Serum Alpha-Fetoprotein and MAGE-A3-Specific Cytotoxic T Lymphocytes in Peripheral Blood for Diagnosis of Hepatocellular Carcinoma

Table 3

Survival comparison of HCC groups with different frequencies of MAGE-A3+ CTL.

Mean survival, month1-year survival rate3-year survival rate5-year survival rateLog rank test value

Cell frequency of MAGE-A3+ CTL ≥ 0.67% 91.3%43.0%21.5%0.099

Cell frequency of MAGE-A3+ CTL < 0.67% 63.8%45.7%38.1%